Acquired TSC1 Mutation as a Mechanism of Alectinib Resistance in ALK -Fused Leiomyosarcoma: Response to Combined ALK and Mammalian Target of Rapamycin Inhibition.
Saved in:
| Title: | Acquired TSC1 Mutation as a Mechanism of Alectinib Resistance in ALK -Fused Leiomyosarcoma: Response to Combined ALK and Mammalian Target of Rapamycin Inhibition. |
|---|---|
| Authors: | Posner, Alisa1 (AUTHOR), Rosenberg, Carol2 (AUTHOR), Esselen, Katharine M.3,4 (AUTHOR), Kelly, Andrew5 (AUTHOR), Bockorny, Bruno4,6 (AUTHOR) bbockorn@bidmc.harvard.edu |
| Source: | JCO Precision Oncology. 7/23/2026, Vol. 10, p1-6. 6p. |
| Database: | Academic Search Ultimate |
| ISSN: | 24734284 |
|---|---|
| DOI: | 10.1200/PO-26-00046 |
